Cargando…

Oligofructose Provides Laxation for Irregularity Associated with Low Fiber Intake

Inadequate dietary fiber intake contributes to the prevalent irregularity and constipation in Western countries. Although eating adequate amounts of fibers from fiber-rich foods, foods with added fibers and dietary fiber supplements is considered the first option for improving laxation, the efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Buddington, Randal K., Kapadia, Cavita, Neumer, Franka, Theis, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748822/
https://www.ncbi.nlm.nih.gov/pubmed/29258261
http://dx.doi.org/10.3390/nu9121372
_version_ 1783289481325969408
author Buddington, Randal K.
Kapadia, Cavita
Neumer, Franka
Theis, Stephan
author_facet Buddington, Randal K.
Kapadia, Cavita
Neumer, Franka
Theis, Stephan
author_sort Buddington, Randal K.
collection PubMed
description Inadequate dietary fiber intake contributes to the prevalent irregularity and constipation in Western countries. Although eating adequate amounts of fibers from fiber-rich foods, foods with added fibers and dietary fiber supplements is considered the first option for improving laxation, the efficacy can vary among types of fibers. The present study is a randomized control trial that included healthy adult participants with ≤3 bowel movements/week and a habitual low dietary fiber intake in a parallel design to evaluate the benefits for laxation by supplementing the daily diet with oligofructose (Orafti(®) P95; OF), a fermentable source of fiber and established prebiotic (n = 49); maltodextrin was the placebo (n = 48). After a run-in phase, OF was initially provided at 5 g/day, then increased to 10 and 15 g/day with four weeks for each phase. Stool frequency (bowel movements per week) for the OF and maltodextrin (MD) groups were initially similar (3.98 ± 1.49 vs. 4.06 ± 1.48), did not change for the placebo group, but increased for the OF group with the difference significant at 15 g/day (p = 0.023). Stool consistency was similar and remained unchanged at all doses for both groups. Gastrointestinal sensations were low for both groups. Laxation benefits were especially pronounced for participants with >13 g/day habitual dietary fiber intake, with significant laxation at 10 g and 15 g OF/day (p = 0.04 and p = 0.004, respectively) A daily supplement with a short-chain inulin-type fructan derived from chicory roots, i.e., oligofructose (Orafti(®) P95) provided a laxation effect without causing gastrointestinal (GI) distress for healthy participants with irregularity associated with low dietary fiber intake.
format Online
Article
Text
id pubmed-5748822
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-57488222018-01-07 Oligofructose Provides Laxation for Irregularity Associated with Low Fiber Intake Buddington, Randal K. Kapadia, Cavita Neumer, Franka Theis, Stephan Nutrients Article Inadequate dietary fiber intake contributes to the prevalent irregularity and constipation in Western countries. Although eating adequate amounts of fibers from fiber-rich foods, foods with added fibers and dietary fiber supplements is considered the first option for improving laxation, the efficacy can vary among types of fibers. The present study is a randomized control trial that included healthy adult participants with ≤3 bowel movements/week and a habitual low dietary fiber intake in a parallel design to evaluate the benefits for laxation by supplementing the daily diet with oligofructose (Orafti(®) P95; OF), a fermentable source of fiber and established prebiotic (n = 49); maltodextrin was the placebo (n = 48). After a run-in phase, OF was initially provided at 5 g/day, then increased to 10 and 15 g/day with four weeks for each phase. Stool frequency (bowel movements per week) for the OF and maltodextrin (MD) groups were initially similar (3.98 ± 1.49 vs. 4.06 ± 1.48), did not change for the placebo group, but increased for the OF group with the difference significant at 15 g/day (p = 0.023). Stool consistency was similar and remained unchanged at all doses for both groups. Gastrointestinal sensations were low for both groups. Laxation benefits were especially pronounced for participants with >13 g/day habitual dietary fiber intake, with significant laxation at 10 g and 15 g OF/day (p = 0.04 and p = 0.004, respectively) A daily supplement with a short-chain inulin-type fructan derived from chicory roots, i.e., oligofructose (Orafti(®) P95) provided a laxation effect without causing gastrointestinal (GI) distress for healthy participants with irregularity associated with low dietary fiber intake. MDPI 2017-12-18 /pmc/articles/PMC5748822/ /pubmed/29258261 http://dx.doi.org/10.3390/nu9121372 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Buddington, Randal K.
Kapadia, Cavita
Neumer, Franka
Theis, Stephan
Oligofructose Provides Laxation for Irregularity Associated with Low Fiber Intake
title Oligofructose Provides Laxation for Irregularity Associated with Low Fiber Intake
title_full Oligofructose Provides Laxation for Irregularity Associated with Low Fiber Intake
title_fullStr Oligofructose Provides Laxation for Irregularity Associated with Low Fiber Intake
title_full_unstemmed Oligofructose Provides Laxation for Irregularity Associated with Low Fiber Intake
title_short Oligofructose Provides Laxation for Irregularity Associated with Low Fiber Intake
title_sort oligofructose provides laxation for irregularity associated with low fiber intake
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748822/
https://www.ncbi.nlm.nih.gov/pubmed/29258261
http://dx.doi.org/10.3390/nu9121372
work_keys_str_mv AT buddingtonrandalk oligofructoseprovideslaxationforirregularityassociatedwithlowfiberintake
AT kapadiacavita oligofructoseprovideslaxationforirregularityassociatedwithlowfiberintake
AT neumerfranka oligofructoseprovideslaxationforirregularityassociatedwithlowfiberintake
AT theisstephan oligofructoseprovideslaxationforirregularityassociatedwithlowfiberintake